Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis
該当なし
完了
NCT04972929
| 対象疾患 | Multiple Sclerosis, Relapsing-Remitting |
|---|
| 相 | 該当なし |
|---|
| スポンサー | University of Alabama at Birmingham |
|---|
| ステータス | 完了 |
|---|
| 参加者数 | 26 名 |
|---|
| 介入（薬剤） | Spinal Manipulation, Sham Spinal Manipulation |
|---|
| 開始日 | 2023年9月15日 |
|---|
| 完了日 | 2025年3月12日 |
|---|
| 結果公開日 | 2026年7月20日 |
|---|
概要
Multiple sclerosis (MS) is an inflammatory autoimmune disease associated with an imbalance between pro- and anti-inflammatory markers (cytokines) resulting in a demyelinating and neurodegenerative disease. There is early evidence that spinal manipulation (chiropractic care) is better than control in influencing immune (cytokine) activity in asymptomatic participants, but few studies have been completed in participants with chronic inflammatory conditions, such as MS. The purpose of this project is to examine the immediate (after a single thoracic spinal manipulation treatment) and summative impact (after 8 thoracic spinal manipulation treatments occurring over 4 weeks) on pro-inflammatory (interleukin (IL) IL-1ß, IL-2, IL-6, Tumor necrosis factor-alpha) and anti-inflammatory (IL-4, IL-10) plasma cytokines 20 minutes and 2 hours after thoracic spinal manipulation in participants diagnosed with neuroinflammatory relapsing-remitting MS (RR-MS). Spinal manipulation treatment will be limited to the thoracic spine. Secondary outcomes will include determining the impact of 8 thoracic spinal manipulations on fatigue, cognitive processing speed, pain, depression, sleep, and motor function t
IL-6 Serum Inflammatory Cytokine Levels
From baseline to after 8th treatment at 4 weeks · pg/mL
| Spinal Manipulation/Trigger Point Therapy | 3.85 ± 6.01 pg/mL |
|---|
| Sham-spinal Manipulation | 2.76 ± 4.77 pg/mL |
|---|
| Mean Difference (Final Values) | -0.24 (95% CI -0.78–0.30) |
|---|
IL-4 Serum Inflammatory Cytokine Levels
From baseline to after 8th treatment at 4 weeks · pg/ML
| Thoracic Spinal Manipulation/Trigger Point Therapy | 83.85 ± 187.51 pg/ML |
|---|
| Sham-spinal Manipulation Group | 73.36 ± 198.60 pg/ML |
|---|
| Mean Difference (Final Values) | -0.03 (95% CI -4.69–4.62) |
|---|
IL-10 Serum Inflammatory Cytokine Levels
From baseline to after 8th treatment at 4 weeks · pg/ML
| Thoracic Spinal Manipulation/Trigger Point Therapy | 12.01 ± 25.01 pg/ML |
|---|
| Sham-manipulation Group | 8.82 ± 17.14 pg/ML |
|---|
| Mean Difference (Final Values) | 0.15 (95% CI -1.32–1.85) |
|---|
BENITIONS で見る
ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
すべての治験
このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。